Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

eisai co., ltd. - aspirin; dihydroxyaluminum aminoacetate; magnesium carbonate - light orange tablet, diameter 8.0 mm, thickness 3.8 mm

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis uk limited - dihydroxyaluminum sodium carbonate - granules for oral suspension

United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - diclona patch is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product. diclona patch is contraindicated in patients with a known hypersensitivity to diclofenac sodium. diclona patch is contraindicated in patients in the setting of coronary artery bypass graft (cabg) surgery.

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - diclona patch is indicated for relief of pain associated with arthritis, backache, cramps, discomfort, neckache, soreness, sprains, strains. it should be applied only to intact skin. sun avoidance is indicated during therapy. diclona patch is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product. diclona patch is contraindicated in patients with a known hypersensitivity to diclofenac sodium. diclona patch is contraindicated in patients in the setting of coronary artery bypass graft (cabg) surgery.

United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - uses: temporarily relieves mild to moderate aches and pains of muscles and joints associated with: - muscle soreness - strains - sprains - arthritis - simple backache - muscle stiffness - bruises instructions for use: - clean and dry affected area - open pouch and remove one patch - remove protective film from patch - apply one patch to the affected area of pain and leave in place for 8 to 12 hours - if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours - only use one patch at a time - do not use more than 2 patches per day - wash hands with soup and water after applying or removing patch - reseal pouch containing unused patches immediately after each use

United States - English - NLM (National Library of Medicine)

neptune products - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - uses: temporarily relieves mild to moderate aches and pains of muscles and joints associated with: - muscle soreness - strains - sprains - arthritis - simple backache - muscle stiffness - bruises instructions for use: - clean and dry affected area - open pouch and remove one patch - remove protective film from patch - apply one patch to the affected area of pain and leave in place for 8 to 12 hours - if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours - only use one patch at a time - do not use more than 2 patches per day - wash hands with soup and water after applying or removing patch - reseal pouch containing unused patches immediately after each use

United States - English - NLM (National Library of Medicine)

strand health group - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - counterirritant arthritis pain reliever topical anesthetic topical analgesic counterirritant for the temporary relief of joint pain, muscle pain, and inflammation associated with: - arthritis - backache - discomfort - cramps - neckache - soreness - sprains - strains this product may take up to 7 days to work for arthritis pain. - on damaged, irritated, or infected skin - with a bandage or heating pad - if you are allergic to any ingredients in this product - right before or after heart surgery - in the eyes, nose, or mouth - otherwise as directed - any of the warnings apply to you - you are taking a diuretic - you are taking any other drugs - you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke - excessive skin irritation develops - condition worsens - symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

United States - English - NLM (National Library of Medicine)

puretek corporation - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin is indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased

New Zealand - English - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - didanosine 100mg;  ;   - chewable/dispersible tablet - 100 mg - active: didanosine 100mg     excipient: aspartame dihydroxyaluminium sodium carbonate hydrated silica magnesium hydroxide magnesium stearate microcrystalline cellulose povidone sodium citrate dihydrate sucrose wintergreen oil

New Zealand - English - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - didanosine 150mg;  ;   - chewable/dispersible tablet - 150 mg - active: didanosine 150mg     excipient: aspartame dihydroxyaluminium sodium carbonate hydrated silica magnesium hydroxide magnesium stearate microcrystalline cellulose povidone sodium citrate dihydrate sucrose wintergreen oil